• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      April 2020, Volume 6, Issue 5

      March 2020, Volume 6, Issue 4

      Focus on Lymphoid & Plasma Cell Malignancies (Volume 6, Issue 4.1)

      February 2020, Volume 6, Issue 3

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Geoffrey L. Uy, MD

    Geoffrey L. Uy, MD

    Associate professor of medicine at the Washington University School of Medicine in St. Louis, Missouri
    • Should ATRA be held in a patient with acute promyelocytic leukemia and a high WBC count? Saturday, August 1st, 2015

      This month, Geoffrey L. Uy, MD, answers a question about white blood cell counts in a patient being treated for acute promyelocytic leukemia.

    admin
    Advertisement

    Current Issue

    April 2020, Volume 6, Issue 5

    Wednesday, April 1, 2020
    This issue examines immunization guidelines for patients with hematologic disorders, considers medical education amid the coronavirus pandemic, and more.
    Recent Posts
    • Editor’s Corner: At World’s End
    • Aveo and Biodesix Stop Trials of Ficlatuzumab for Acute Myeloid Leukemia
    • FDA Grants Orphan Drug Designations to Avatrombopag and CLR 131
    • When, and How, Can We Safely Relax Coronavirus Lockdown Measures?

    Meeting Coverage

    Study Examines Trends in Real-World Treatment Sequencing Patterns for CLL/SLL

    Sunday, March 1, 2020

    Early-Phase Study Shows Promising Response Rates With Venetoclax Plus Navitoclax in ALL

    Sunday, March 1, 2020

    Editor`s Corner

    Editor’s Corner: At World’s End

    Friday, April 3, 2020

    COVID-19: The Global Disrupter of Medical Education

    Wednesday, April 1, 2020
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy